New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

Add Yahoo as a preferred source to see more of our stories on Google. A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth ...

Similar 3-year metastasis-free survival, fewer hot flashes, more gynecomastia ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

—As more men are cured of prostate cancer, or are long-term survivors, the challenges of survivorship are in the spotlight. Improved screening practices, earlier detection, and better therapies have ...

Prostate cancer affects one in eight men in the U.S. over their lifetime, which is the same rate as women and breast cancer.

With the campaign, Highlights REAL, they are spotlighting the everyday experiences of advanced prostate cancer patients and ...